We report the synthesis and characterization of a bimetallic complex derived from a new family of potent and selective metalloinsertors containing an unusual Rh–O axial coordination. This complex incorporates a monofunctional platinum center containing only one labile site for coordination to DNA, rather than two, and coordinates DNA nonclassically through adduct formation in the minor groove. This conjugate displays bifunctional, interdependent binding of mismatched DNA via metalloinsertion at a mismatch as well as covalent platinum binding. DNA sequencing experiments revealed that the preferred site of platinum coordination is not the traditional N7-guanine site in the major groove, but rather N3-adenine in the minor groove. The complex a...
Rhodium metalloinsertors are a unique set of metal complexes that bind specifically to DNA base pair...
Deficiencies in the mismatch repair pathway are assocd. with several types of cancers, as well as re...
DNA base pair mismatches are a promising target for chemotherapeutic design due to their relative ab...
We report the synthesis and characterization of a bimetallic complex derived from a new family of po...
We report the synthesis and characterization of a bimetallic complex derived from a new family of po...
We report the synthesis and characterization of a bimetallic conjugate (RhPt) in which an oxaliplati...
Rhodium metalloinsertors are octahedral complexes that bind DNA mismatches with high affinity and sp...
The success of cisplatin as an anticancer agent has led to the development of a multitude of inorg. ...
Deficiencies in the mismatch repair (MMR) machinery lead to DNA defects that cause cancer. Cancers t...
DNA has been exploited as a biological target of chemotherapeutics since the 1940s. Traditional chem...
Rhodium metalloinsertors are octahedral complexes that bind DNA mismatches with high affinity and sp...
The Barton laboratory has established that octahedral rhodium complexes bearing the sterically expan...
Deficiencies in mismatch repair (MMR) are associated with carcinogenesis. Rhodium metalloinsertors b...
Mismatches in DNA occur naturally during replication and as a result of endogenous DNA damaging agen...
Rhodium metalloinsertors are octahedral complexes that bind DNA mismatches with high affinity and sp...
Rhodium metalloinsertors are a unique set of metal complexes that bind specifically to DNA base pair...
Deficiencies in the mismatch repair pathway are assocd. with several types of cancers, as well as re...
DNA base pair mismatches are a promising target for chemotherapeutic design due to their relative ab...
We report the synthesis and characterization of a bimetallic complex derived from a new family of po...
We report the synthesis and characterization of a bimetallic complex derived from a new family of po...
We report the synthesis and characterization of a bimetallic conjugate (RhPt) in which an oxaliplati...
Rhodium metalloinsertors are octahedral complexes that bind DNA mismatches with high affinity and sp...
The success of cisplatin as an anticancer agent has led to the development of a multitude of inorg. ...
Deficiencies in the mismatch repair (MMR) machinery lead to DNA defects that cause cancer. Cancers t...
DNA has been exploited as a biological target of chemotherapeutics since the 1940s. Traditional chem...
Rhodium metalloinsertors are octahedral complexes that bind DNA mismatches with high affinity and sp...
The Barton laboratory has established that octahedral rhodium complexes bearing the sterically expan...
Deficiencies in mismatch repair (MMR) are associated with carcinogenesis. Rhodium metalloinsertors b...
Mismatches in DNA occur naturally during replication and as a result of endogenous DNA damaging agen...
Rhodium metalloinsertors are octahedral complexes that bind DNA mismatches with high affinity and sp...
Rhodium metalloinsertors are a unique set of metal complexes that bind specifically to DNA base pair...
Deficiencies in the mismatch repair pathway are assocd. with several types of cancers, as well as re...
DNA base pair mismatches are a promising target for chemotherapeutic design due to their relative ab...